Danaher (NYSE:DHR) EVP Sells 2,100 Shares of Stock

Key Points

• Danaher EVP Gregory Milosevich sold 2,100 shares for about $484,302 at an average price of $230.62, reducing his stake by 8.58% to 22,367 shares.
• Danaher reported quarterly EPS of $2.11, beating the $1.92 analyst consensus; revenue was $6.55 billion, and year-over-year revenue increased 8.3%.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $242.91. Shares traded at $236.41 in the article’s cited session.

Danaher Corporation (NYSE:DHR - Get Free Report) EVP Gregory Milosevich sold 2,100 shares of the company's stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president owned 22,367 shares of the company's stock, valued at $5,158,277.54. This trade represents a 8.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Danaher Price Performance

NYSE DHR traded up $1.29 on Tuesday, reaching $236.41. 3,395,945 shares of the stock traded hands, compared to its average volume of 4,447,668. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a market cap of $166.32 billion, a price-to-earnings ratio of 38.69, a P/E/G ratio of 2.95 and a beta of 0.76. The firm's fifty day simple moving average is $220.65 and its 200 day simple moving average is $201.57. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping analysts' consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The company's quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.89 EPS. As a group, research analysts predict that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher's dividend payout ratio is presently 26.19%.

Institutional Investors Weigh In On Danaher

Hedge funds have recently modified their holdings of the stock. Main Street Group LTD acquired a new stake in Danaher during the 1st quarter worth approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in Danaher in the second quarter valued at approximately $25,000. Marquette Asset Management LLC lifted its position in Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate's stock valued at $25,000 after buying an additional 73 shares in the last quarter. Field & Main Bank acquired a new position in Danaher during the second quarter valued at approximately $29,000. Finally, Solstein Capital LLC acquired a new position in Danaher during the second quarter valued at approximately $33,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Barclays raised their price objective on shares of Danaher from $255.00 to $260.00 and gave the company an "overweight" rating in a research report on Thursday, October 22nd. Weiss Ratings upgraded shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, September 16th. TD Cowen increased their target price on shares of Danaher from $255.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday, October 22nd. The Goldman Sachs Group reissued a "buy" rating and set a $275.00 target price on shares of Danaher in a research note on Thursday, October 22nd. Finally, Citigroup raised their target price on shares of Danaher from $230.00 to $270.00 and gave the stock a "buy" rating in a report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average price target of $242.91.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company's businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.